×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy ...
Yahoo Finance
Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE)...
1 month ago
Lixte CEO Takes On a New Course
Los Angeles Business Journal
Pasadena-based pharmaceutical company Lixte Biotechnology Holdings Inc.'s new chief executive is also charting a new course for the company...
2 months ago
Mixed Shelf Filing Gives Micro Cap Delayed Boost
The Globe and Mail
Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.
2 days ago
Lixte Biotechnology enters exclusive immuno-oncology patent license agreement with NINDS, NCI
The Cancer Letter
Lixte Biotechnology enters exclusive immuno-oncology patent license agreement with NINDS, NCI ... Lixte Biotechnology has signed an exclusive...
1 month ago
Should You Buy Lixte Biotechnology Holdings Inc (LIXT) Stock Monday Morning?
InvestorsObserver
LIXT gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading...
4 weeks ago
LIXT Stock: 8 Things to Know About Lixte Biotechnology As Shares Blast Off
AOL.com
Lixte Biotechnology (NASDAQ:LIXT) stock is heading higher on Friday despite a lack of news concerning the company. Source: Shutterstock The rise in price...
3 weeks ago
LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach
GlobeNewswire
09, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage...
6 months ago
LIXT Stock Quote Price and Forecast
CNN
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein...
1 month ago
Why Lixte Biotechnology Stock Is Soaring - Lixte Biotechnology (NASDAQ:LIXT)
Benzinga
Lixte Biotechnology Holdings, Inc. LIXT-5.52%. + Free Alerts. shares are trading higher Wednesday after the company announced the...
1 month ago
Lixte Biotechnology provides update on progress with LB-100 - TipRanks.com
Tipranks
LIXTE Biotechnology provided an update on the Company's progress with its proprietary compound, LB-100. “Clinical trials are underway at leading cancer...
1 month ago